{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:39Z","timestamp":1792784919900,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Italian Association for Shwachman-Diamond Syndrome"},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK132812"],"award-info":[{"award-number":["R01DK132812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Velosano 2nd Chance 4 Kids Lisa Dean Moseley Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-63137-3","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T09:57:13Z","timestamp":1756807033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series"],"prefix":"10.1038","volume":"16","author":[{"given":"Valentino","family":"Bezzerri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9275-8019","authenticated-orcid":false,"given":"Anca Manuela","family":"Hristodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9274-0214","authenticated-orcid":false,"given":"Genevieve M.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Meneghelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Brignole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9982-4100","authenticated-orcid":false,"given":"Christian","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Baldisseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9598-2673","authenticated-orcid":false,"given":"Antonio","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Menichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Valli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-9054","authenticated-orcid":false,"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9547","authenticated-orcid":false,"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-7248","authenticated-orcid":false,"given":"Marco","family":"Cipolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"63137_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng1062","volume":"33","author":"GR Boocock","year":"2003","unstructured":"Boocock, G. R. et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet. 33, 97\u2013101 (2003).","journal-title":"Nat. Genet."},{"key":"63137_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.hoc.2018.04.006","volume":"32","author":"AS Nelson","year":"2018","unstructured":"Nelson, A. S. & Myers, K. C. Diagnosis, treatment, and molecular pathology of Shwachman-Diamond syndrome. Hematol. Oncol. Clin. North Am. 32, 687\u2013700 (2018).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"63137_CR3","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","volume":"97","author":"J Donadieu","year":"2012","unstructured":"Donadieu, J. et al. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica 97, 1312\u20131319 (2012).","journal-title":"Haematologica"},{"key":"63137_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jbior.2017.09.002","volume":"67","author":"AJ Warren","year":"2018","unstructured":"Warren, A. J. Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome. Adv. Biol. Regul. 67, 109\u2013127 (2018).","journal-title":"Adv. Biol. Regul."},{"key":"63137_CR5","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/s41390-022-02009-8","volume":"92","author":"AS Thompson","year":"2022","unstructured":"Thompson, A. S. et al. Shwachman Diamond syndrome: narrow genotypic spectrum and variable clinical features. Pediatr. Res. 92, 1671\u20131680 (2022).","journal-title":"Pediatr. Res."},{"key":"63137_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch, E. M. et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 447, 87\u201391 (2007).","journal-title":"Nature"},{"key":"63137_CR7","doi-asserted-by":"crossref","unstructured":"McDonald, C. M. et al. Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients. J. Comp. Eff. Res. 11, 139\u2013155 (2021).","DOI":"10.2217\/cer-2021-0196"},{"key":"63137_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30080-6","volume":"13","author":"S Huang","year":"2022","unstructured":"Huang, S. et al. Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination. Nat. Commun. 13, 2413 (2022).","journal-title":"Nat. Commun."},{"key":"63137_CR9","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","volume":"182","author":"I Sermet-Gaudelus","year":"2010","unstructured":"Sermet-Gaudelus, I. et al. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis. Am. J. Respir. Crit. Care Med. 182, 1262\u20131272 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"63137_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1096\/fj.13-240044","volume":"28","author":"M Li","year":"2014","unstructured":"Li, M., Andersson-Lendahl, M., Sejersen, T. & Arner, A. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment. FASEB J. 28, 1593\u20131599 (2014).","journal-title":"FASEB J."},{"key":"63137_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.omtn.2017.05.002","volume":"7","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Efficacy of postnatal in vivo nonsense suppression therapy in a Pax6 mouse model of aniridia. Mol. Ther. Nucleic Acids 7, 417\u2013428 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"63137_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2217\/cer-2019-0171","volume":"9","author":"E Mercuri","year":"2020","unstructured":"Mercuri, E. et al. Safety and effectiveness of ataluren: comparison of results from the STRIDE registry and CINRG DMD natural history study. J. Comp. Eff. Res. 9, 341\u2013360 (2020).","journal-title":"J. Comp. Eff. Res."},{"key":"63137_CR13","doi-asserted-by":"crossref","unstructured":"Cipolli, M. et al. Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells. Br. J. Haematol. 204, 292\u2013305 (2023).","DOI":"10.1111\/bjh.19134"},{"key":"63137_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27597","volume":"66","author":"V Bezzerri","year":"2019","unstructured":"Bezzerri, V. et al. Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome. Pediatr. Blood Cancer 66, e27597 (2019).","journal-title":"Pediatr. Blood Cancer"},{"key":"63137_CR15","doi-asserted-by":"crossref","unstructured":"Vella, A. et al. mTOR and STAT3 pathway hyper-activation is associated with evated interleukin-6 levels in patients with Shwachman-Diamond syndrome: further evidence of lymphoid lineage impairment. Cancers 12, 597 (2020).","DOI":"10.3390\/cancers12030597"},{"key":"63137_CR16","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1038\/sj.onc.1209883","volume":"25","author":"C Mayer","year":"2006","unstructured":"Mayer, C. & Grummt, I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 25, 6384\u20136391 (2006).","journal-title":"Oncogene"},{"key":"63137_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jcmm.12744","volume":"20","author":"V Thada","year":"2016","unstructured":"Thada, V., Miller, J. N., Kov\u00e1cs, A. D. & Pearce, D. A. Tissue-specific variation in nonsense mutant transcript level and drug-induced read-through efficiency in the Cln1(R151X) mouse model of INCL. J. Cell Mol. Med. 20, 381\u2013385 (2016).","journal-title":"J. Cell Mol. Med."},{"key":"63137_CR18","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/pbc.24260","volume":"59","author":"A Minelli","year":"2012","unstructured":"Minelli, A. et al. Incidence of Shwachman-Diamond syndrome. Pediatr. Blood Cancer 59, 1334\u20131335 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"63137_CR19","unstructured":"Stetler-Stevenson, M. et al Clinical flow cytometric analysis of neoplastic hematolymphoid cells. Approved guideline-Second edition. CLSI document H43-A2 (ISBN 1-56238-635-2) (Clinical and Laboratory Standards Institute, 2007)."},{"key":"63137_CR20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41375-017-0007-7","volume":"32","author":"J Malcikova","year":"2018","unstructured":"Malcikova, J. et al. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. Leukemia 32, 1070\u20131080 (2018).","journal-title":"Leukemia"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63137-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:28:53Z","timestamp":1757478533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63137-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63137"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63137-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5231941\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.B. and M.C. are co-inventors of the patent US 11,207,300 B2 \u201cMethod of treatment of Shwachman\u2013Diamond syndrome\u201d. All authors declare that they have no additional competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research included local and foreign researchers throughout the research process. All clinical data were analyzed by co-authors after de-anonymization of samples, according to pre-defined sharing measures between the involved research groups. Roles and responsibilities were agreed amongst collaborators ahead of the research. This study was approved by the Ethics Committee of the Azienda Ospedaliera Universitaria Integrata, Verona, Italy (approvals No. 4090 and 4182 CESC). Research did not result in stigmatization, incrimination, discrimination or otherwise personal risk to participants. Local and regional research relevant to this study was taken into account in citations. Participants received no compensation for their involvement in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8189"}}